Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus Journal Article


Authors: Suntharalingam, M.; Moughan, J.; Coia, L. R.; Krasna, M. J.; Kachnic, L.; Haller, D. G.; Willet, C. G.; John, M. J.; Minsky, B. D.; Owen, J. B.
Article Title: Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus
Abstract: Purpose A Patterns of Care Study of patients treated from 1996 to 1999 evaluated the national practice for patients receiving radiation therapy for carcinoma of the esophagus in the United States. Methods A national survey was conducted at 59 institutions in a stratified random sample selected from a master list of radiation therapy facilities throughout the United States. Patient, tumor, and treatment characteristics were evaluated. Multivariate comparisons of survival times were made using the Cox proportional hazards model. Results Adenocarcinoma was diagnosed in 51 % of patients and squamous cell carcinoma in 49% of patients. Sixteen percent of patients were clinical stage (CS) I (using the 1983 American Joint Committee on Cancer system), 39% were CS II, and 33% were CS III. Significant variables in the multivariate analysis of survival times included clinical stage, treatment approach, and facility size. Patients with CS III disease had a higher hazard risk of death as compared with CS I patients (hazard ratio [HR], 2.01 ; P =.001), whereas those treated with chemoradio-therapy followed by surgery (HR, 0.32; P <.0001) had a decreased risk of death compared with chemoradiotherapy-only patients. Patients at small centers had a higher risk of death (HR, 1.32; P =.03) compared with patients treated at larger facilities. Conclusion Concurrent chemoradiotherapy continued to be the most commonly utilized treatment approach during the time period studied. The observation that patients undergoing surgical resection following chemoradiation have a decreased HR or chance of death compared with other treatment schemes supports the need for a randomized trial comparing these strategies.
Keywords: chemotherapy; radiotherapy; oncology; surgery; esophagectomy; chemoradiotherapy; randomized-trial; hospital volume; preoperative chemoradiation
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 10
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-04-01
Start Page: 2325
End Page: 2331
Language: English
DOI: 10.1200/jco.2005.00.448
ACCESSION: WOS:000228260200026
PROVIDER: wos
PUBMED: 15800323
Notes: --- - Article - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bruce Minsky
    306 Minsky